Back to results
US 9,867,794 B2Granted
Regulation of osteopontin
AssigneePathologica LLC
InventorsKenneth G. Hadlock, Hope Lancero, Stephanie Yu, Hien Kim Do
Life of this patent
Estimating the term…
Abstract
The present invention provides methods for the regulation of osteopontin activity in a subject as well as for treating or preventing conditions associated with an increased activity of osteopontin activity in a subject.
Claims1
A method of treating, or alleviating the symptoms of, multiple sclerosis (MS) comprising administering to a subject in need of such treatment an effective amount of MGBG or a salt thereof.
Dependencies are inferred from the claim text.